Luke Miels

chess pieces facing each other
Biotech

JPM25: M&A strategist GSK acquires IDRx for $1B upfront

“We have an opportunity to develop a best-in-class product for patients and move the standard of care ahead after 20 years," GSK CCO Luke Miels said.
Gabrielle Masson Jan 13, 2025 2:00am
cough quarantine COVID sick cold flu

After Merck's cough drama, GSK knew what to do with Bellus asset

Nov 30, 2023 8:00am
buy acquisition deal shopping

Sierra wanted a partnership, but GSK wanted the store

May 3, 2022 11:04am